Literature DB >> 3263240

Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulin.

G Inghirami1, J Simon, J E Balow, G C Tsokos.   

Abstract

Systemic lupus erythematosus (SLE) is characterized by multiple T and B cell abnormalities. This study was designed to investigate the cell surface membrane characteristics of T cells by using single and double immunofluorescence and examine the role of HLA-DR+ T cells in the production of immunoglobulin by B cells. The results presented: (a) confirm the presence of a larger population of T-cells bearing DR antigens in patients with SLE than in normal controls, (b) demonstrate that DR positive cells are equally distributed in helper/inducer and suppressor/cytotoxic subsets of lymphocytes from patients with SLE, (c) show no elevation in the percentage of T cells bearing interleukin 2 (IL-2) receptors, (d) demonstrate that DR positive, but not DR negative T-cells, multiply in the presence of conditioned media and, (e) demonstrate that DR positive T cells provide helper factors which enhance the production of immunoglobulin by B cells. We propose that T-cells bearing DR antigens in patients with SLE are functional in vivo, and may be responsible for the B cell overactivity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263240

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  10 in total

1.  Interleukin-10 receptor expression and signalling were down-regulated in CD4⁺ T cells of lupus nephritis patients.

Authors:  H D Cui; Z M Qi; L L Yang; L Qi; N Zhang; X L Zhang; S Y Du; Y Jiang
Journal:  Clin Exp Immunol       Date:  2011-06-02       Impact factor: 4.330

Review 2.  [Biologics therapy for systemic lupus erythematosus. Current situation].

Authors:  B F Hoyer; T Dörner
Journal:  Z Rheumatol       Date:  2015-04       Impact factor: 1.372

Review 3.  Gene-marked autologous hematopoietic stem cell transplantation of autoimmune disease.

Authors:  R K Burt; M Brenner; W Burns; E Courier; G Firestein; B Hahn; H Heslop; C Link; H McFarland; M Roland; M Territo; G Tsokos; A Traynor
Journal:  J Clin Immunol       Date:  2000-01       Impact factor: 8.317

4.  Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus.

Authors:  E J ter Borg; G Horst; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

5.  B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events.

Authors:  S N Liossis; B Kovacs; G Dennis; G M Kammer; G C Tsokos
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

6.  Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes.

Authors:  G M Kammer; I U Khan; C J Malemud
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

7.  The role of IL-23/IL-17 axis in lupus nephritis.

Authors:  Zheng Zhang; Vasileios C Kyttaris; George C Tsokos
Journal:  J Immunol       Date:  2009-08-05       Impact factor: 5.422

8.  Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus.

Authors:  W A Nockher; R Wigand; W Schoeppe; J E Scherberich
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

9.  Normalization of the lymph node T cell stromal microenvironment in lpr/lpr mice is associated with SU5416-induced reduction in autoantibodies.

Authors:  Susan Chyou; Sha Tian; Eric H Ekland; Theresa T Lu
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

10.  Assessment of in vivo frequency of mutated T cells in patients with systemic lupus erythematosus.

Authors:  F Gmelig-Meyling; S Dawisha; A D Steinberg
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.